Search results
Results from the WOW.Com Content Network
Helicobacter heilmannii s.s. (H. heilmannii s.s.) is a species within the Helicobacter genus of Gram negative bacteria. [1] Helicobacter pylori (H. pylori) is by far the best known Helicobacter species primarily because humans infected with it may develop gastrointestinal tract diseases such as stomach inflammation, stomach ulcers, duodenal ulcers, stomach cancers of the non-lymphoma type, and ...
The current taxonomy of Helicobacter bacteria is somewhat complex and incomplete, with new species currently being considered as possibly belonging to this genus. [2] [6] [7] Within the Helicobacter genus, H. heilmannii s. l. is a group of Helicobacter species that are distinguished from H. pylori by being two- to three-fold larger in size (they are 4-10 micrometers in length and 0.5-0.8 ...
Helicobacter heilmannii sensu lato (i.e. H. heilmanni s.l.) is a grouping of non-H. pylori Helicobacter species that take as part of their definition a similarity to H. pylori in being associated with the development of stomach inflammation, stomach ulcers, [11] duodenum ulcers, [12] stomach cancers that are not lymphomas, and extranodal ...
“Oils used for oil pulling tend to have antibacterial properties, and over time, can help improve the balance of the oral microbiome, leading to fewer cavities,” says Dr. Rawdin. But don't ...
If you're tired of your stomach feeling like a distended balloon, you're not alone. In fact, it is pretty common. A study shows that almost 18% of people experience bloating at least once a week ...
Helicobacter pylori eradication protocols is a standard name for all treatment protocols for peptic ulcers and gastritis in the presence of Helicobacter pylori infection. The primary goal of the treatment is not only temporary relief of symptoms but also total elimination of H. pylori infection.
A new study found that some medications could have the unintended benefit of reducing dementia risk, while others could increase the risk. A doctor comments on the findings.
The European Helicobacter Pylori Study Group published the Maastricht 2-2000 Consensus Report, suggesting a "test-and-treat" strategy for H. pylori in young patients without atypical symptoms. This strategy advocates the use of noninvasive testing to evaluate for H. pylori and simply treating if found, even in the absence of ulcer disease ...